Pharmaceutical compositions for treating depression and anxiety

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 36/725 (2006.01) A61K 36/258 (2006.01) A61K 36/484 (2006.01) A61P 25/22 (2006.01) A61P 25/24 (2006.01)

Patent

CA 2707114

Pharmaceutical compositions or functional foods for treating depression and anxiety comprising ginseng saponin (Rg1 + Rb1), glycyrrhizic acid and jujuba cAMP. Experiments demonstrate that as compared with the preferred drug fro treating depression and anxiety paroxetine and diazepam in the art, the present invention has significant anti-depression and anxielytic efficacy.

L'invention concerne des compositions pharmaceutiques ou des aliments fonctionnels permettant de traiter la dépression et l'anxiété. Ces compositions pharmaceutiques ou ces aliments fonctionnels comprennent de la saponine de ginseng (Rg1 + Rb1), de l'acide glycyrrhizique et de l'AMPc de jujube. Des expériences ont démontré que l'invention présente une efficacité anti-dépression et anxiolytique bien supérieure à celle de la paroxétine et du diazépame qui sont des médicaments de traitement de la dépression et de l'anxiété de l'état de la technique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical compositions for treating depression and anxiety does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compositions for treating depression and anxiety, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions for treating depression and anxiety will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2006695

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.